Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Requirement for ErbB2/ErbB signaling in developing cartilage and bone.

Fisher MC, Clinton GM, Maihle NJ, Dealy CN.

Dev Growth Differ. 2007 Aug;49(6):503-13. Epub 2007 Jun 7.

PMID:
17555517
2.

Therapeutic potential of epidermal growth factor receptor-related protein.

Reiter JL, Maihle NJ, Clinton GM.

Mol Cancer Ther. 2006 Nov;5(11):2954; author reply 2955. No abstract available.

3.

p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer.

Sáez R, Molina MA, Ramsey EE, Rojo F, Keenan EJ, Albanell J, Lluch A, García-Conde J, Baselga J, Clinton GM.

Clin Cancer Res. 2006 Jan 15;12(2):424-31.

4.

Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.

Staverosky JA, Muldoon LL, Guo S, Evans AJ, Neuwelt EA, Clinton GM.

Clin Cancer Res. 2005 Jan 1;11(1):335-40.

5.

Receptor binding specificities of Herstatin and its intron 8-encoded domain.

Shamieh LS, Evans AJ, Denton MC, Clinton GM.

FEBS Lett. 2004 Jun 18;568(1-3):163-6.

6.

Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.

Jhabvala-Romero F, Evans A, Guo S, Denton M, Clinton GM.

Oncogene. 2003 Nov 6;22(50):8178-86.

PMID:
14603258
8.

NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer.

Molina MA, Sáez R, Ramsey EE, Garcia-Barchino MJ, Rojo F, Evans AJ, Albanell J, Keenan EJ, Lluch A, García-Conde J, Baselga J, Clinton GM.

Clin Cancer Res. 2002 Feb;8(2):347-53.

9.
10.

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor.

Doherty JK, Bond C, Jardim A, Adelman JP, Clinton GM.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10869-74.

11.

An alternative HER-2/neu transcript of 8 kb has an extended 3'UTR and displays increased stability in SKOV-3 ovarian carcinoma cells.

Doherty JK, Bond CT, Hua W, Adelman JP, Clinton GM.

Gynecol Oncol. 1999 Sep;74(3):408-15.

PMID:
10479501
12.

NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.

Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM.

Cancer Res. 1998 Nov 15;58(22):5123-9.

13.

Estrogen action in human ovarian cancer.

Clinton GM, Hua W.

Crit Rev Oncol Hematol. 1997 Jan;25(1):1-9. Review.

PMID:
9134308
14.

Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures.

Severino MF, Murray MJ, Brandon DD, Clinton GM, Burry KA, Novy MJ.

Mol Hum Reprod. 1996 Nov;2(11):823-8.

PMID:
9237221
15.

Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells.

Clinton GM, Rougeot C, Derancourt J, Roger P, Defrenne A, Godyna S, Argraves WS, Rochefort H.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):316-20.

16.

SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.

Hua W, Christianson T, Rougeot C, Rochefort H, Clinton GM.

J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):279-89.

PMID:
8541224
17.

Estrogen receptor gene expression in human uterine leiomyomata.

Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, Warner C, Clinton GM.

J Clin Endocrinol Metab. 1995 Jun;80(6):1876-81.

PMID:
7775635
18.

Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas.

Brandon DD, Bethea CL, Strawn EY, Novy MJ, Burry KA, Harrington MS, Erickson TE, Warner C, Keenan EJ, Clinton GM.

Am J Obstet Gynecol. 1993 Jul;169(1):78-85.

PMID:
8333481
19.
20.

Disulfide-linked and noncovalent dimers of p185HER-2 in human breast carcinoma cells.

Lin YJ, Christianson TA, Clinton GM.

J Cell Biochem. 1992 Jul;49(3):290-5.

PMID:
1379605
21.
22.

Generation and use of anti-peptide antibodies directed against catalytic domain of protein kinases.

Clinton GM, Brown NA.

Methods Enzymol. 1991;200:463-74. No abstract available.

PMID:
1720189
23.
24.

Serum tyrosine kinase activity and neoplastic disease.

Lee PL, Clinton GM.

Recent Results Cancer Res. 1989;113:32-40. No abstract available.

PMID:
2756235
26.

Cancer-associated lactate dehydrogenase is a tyrosylphosphorylated form of human LDH-A, skeletal muscle isoenzyme.

Li SS, Pan YE, Sharief FS, Evans MJ, Lin MF, Clinton GM, Holbrook JJ.

Cancer Invest. 1988;6(1):93-101.

PMID:
3365574
27.

Developmental expression of tyrosyl kinase activity in human serum.

Lin MF, Bailey-Wilson JE, Elston RC, Clinton GM.

Hum Biol. 1987 Jun;59(3):549-56. No abstract available.

PMID:
3610126
29.
30.

Characterization of tyrosyl kinase activity in human serum.

Lin MF, Lee PL, Clinton GM.

J Biol Chem. 1985 Feb 10;260(3):1582-7.

31.
32.
33.

Intrahepatic assembly of very low density lipoproteins. Phosphorylation of small molecular weight apolipoprotein B.

Davis RA, Clinton GM, Borchardt RA, Malone-McNeal M, Tan T, Lattier GR.

J Biol Chem. 1984 Mar 25;259(6):3383-6.

34.

RNP template of vesicular stomatitis virus regulates transcription and replication functions.

Perrault J, Clinton GM, McClure MA.

Cell. 1983 Nov;35(1):175-85.

PMID:
6313223
35.

Host-dependent phosphorylation and kinase activity associated with vesicular stomatitis virus.

Clinton GM, Guerina NG, Guo HY, Huang AS.

J Biol Chem. 1982 Mar 25;257(6):3313-9.

36.

Distribution of phosphoserine, phosphothreonine and phosphotyrosine in proteins of vesicular stomatitis virus.

Clinton GM, Huang AS.

Virology. 1981 Jan 30;108(2):510-4. No abstract available.

PMID:
6162272
37.

Phosphoproteins of vesicular stomatitis virus: identity and interconversion of phosphorylated forms.

Clinton GM, Burge BW, Huang AS.

Virology. 1979 Nov;99(1):84-94. No abstract available.

PMID:
227166
38.

The matrix (M) protein of vesicular stomatitis virus regulates transcription.

Clinton GM, Little SP, Hagen FS, Huang AS.

Cell. 1978 Dec;15(4):1455-62.

PMID:
215330
39.
41.

The parvovirus MVM: a comparison of heavy and light particle infectivity and their density conversion in vitro.

Clinton GM, Hayashi M.

Virology. 1976 Oct 1;74(1):57-63. No abstract available.

PMID:
982825
42.

The parovivirus MVM: particles with altered structural proteins.

Clinton GM, Hayashi M.

Virology. 1975 Jul;66(1):261-1. No abstract available.

PMID:
1169851
43.

An effect of temperature on the Bacillus subtillis transfer RNA's which respond to codons beginning with U and A correlation with cytokinin activity.

Vold BS, Clinton GM, Spizizen J.

Biochim Biophys Acta. 1970;209(2):396-404. No abstract available.

PMID:
4989257

Supplemental Content

Loading ...
Support Center